Steadymed Revenue, Profits - STDY Quarterly Income Statement

Add to My Stocks
$4.73 $0 (0%) STDY stock closing price Aug 30, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Steadymed stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. Like any other income statement, the STDY income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue decline of 0 when compared to the same period in the past. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Steadymed profit and loss statement with those of the prior corresponding period. Also see Steadymed assets and Steadymed free cash flow for a complete valuation of STDY stock.

View and download details of revenue and profits for Steadymed for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Steadymed Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
Steadymed Gross Profit
----------
Research & Development Expense3.98M3.92M3.2M3.77M3.53M4.1M4.6M6.04M5.3M4.96M
Selling General & Admin Expense3.31M2.15M1.79M1.62M1.58M1.9M2.15M1.92M1.85M1.64M
Income Before Depreciation Depletion Amortization-7.29M-6.08M-4.87M-5.07M-4.8M-5.69M-6.41M-7.69M-7.06M-6.23M
Depreciation Depletion Amortization----------
Non Operating Income----------
Interest Expense2.76M4.15M1.01M-14.17M3.2M12.72M-4.09M2.26M-0.01M-0.06M
Steadymed Pretax Income
-10.05M-10.23M-5.87M9.09M-8M-18.41M-2.33M-9.95M-7.05M-6.16M
Provision for Income Taxes----0.32M------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-10.07M-10.36M-5.9M9.42M-8.15M-18.56M-2.4M-10.01M-7.16M-6.27M
Extraordinary Items & Discontinued Operations----------
Steadymed Profit/ Loss (Net Income)
-10.07M-10.36M-5.9M9.42M-8.15M-18.56M-2.4M-10.01M-7.16M-6.27M
Average Shares used to compute Diluted EPS26.6M26.57M26.82M28.24M24.34M20.14M16.25M17.65M13.59M13.59M
Average Shares used to compute Basic EPS26.6M26.57M26.82M26.56M24.34M20.14M16.25M17.65M13.59M13.59M
Income Before Nonrecurring Items-10.07M-10.36M-5.9M9.42M-8.15M-5.84M-2.4M-10.01M-7.16M-6.27M
Income from Nonrecurring Items------12.72M----
Steadymed Earnings Per Share Basic Net
-0.38-0.39-0.220.35-0.33-0.92-0.12-0.57-0.53-0.46
Steadymed Earnings Per Share Diluted Net
-0.38-0.39-0.22-0.02-0.33-0.92-0.12-0.57-0.53-0.46
EPS Diluted Before Nonrecurring Items-0.38-0.39-0.22-0.02-0.33-0.29-0.12-0.57-0.53-0.46
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Steadymed stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Steadymed revenue chart, implies that the company is growing. It has not been the case with Steadymed. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-10.07M for STDY stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The STDY financials along with Steadymed historical stock prices provide a lot of details about the firm.

Steadymed Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
292.29
Operating Margin
0
Net Profit Margin
0
Dividend Yield
0%